[DOI] [PubMed] [Google Scholar] 12.Huang P.J., Huang Y.C., Su M.F., Yang T.Y., Huang J.R., Jiang C.P
Arshad MA, Soon YK, Azooz RH, Lupwayi NZ, Chang SX
13 These studies may have limitations such as inadequate representation for the full population, insufficient detail on potential additional contributing factors, limited sample sizes, challenges in control selection, and bias in self-reported data, particularly in survey-based methodologies
Side Effect Management: A Professional Approach While lethargy and local irritation are the most common reports, research has identified ways to mitigate these
Although exciting breakthroughs in diabetes medications often lead to questions about their use for other conditions, Mounjaro is not FDA-approved for weight loss
However, a July 2025 study published in eClinicalMedicine notes that people who stop taking Ozempic and other GLP-1s tend to regain the weight they had lost